"With the newly developed immunotherapy, we were able to eliminate fibroblasts efficiently in mice, thus reducing fibrosis in the liver and the lungs, without affecting healthy organ tissue," says ...

Blocking the activity of the protein turns formerly "cold," or immune-resistant, liver tumors in mice into "hot" tumors ... Hodgkin's lymphoma and some types of lung cancer. In some cases, they ...

“With the newly developed immunotherapy, we were able to eliminate fibroblasts efficiently in mice, thus reducing fibrosis in the liver and lungs,” Christian Stockmann, M.D., the study’s ...

Their preclinical studies found that blocking activity of EPO converts formerly “cold” – or immune-resistant – liver tumors in mice into ... and some types of lung cancer.

the study analyzed the presence of lung cancer in non-smokers, using mice as test subjects. The researchers found that, instead of causing mutations, the exposure to pollution resulted in ...

“Diseases like pancreatic cancer or liver ... lung cancer. Higher glycogen levels in these tumors were linked to more ...

This means that there are no effective targeted treatments yet on the market for the roughly 20% of all NSCLCs that have a mutated liver ... lung cancer for 42 days, and found that mice given ...

To better understand the effects of obesity on the liver, researchers compared the livers of typical mice and obese mice after periods of feeding and fasting. The team carried out trans-omics ...

The approach has succeeded in editing DNA in hard-to-reach lung stem cells in mice, with modifications ... lipid nanoparticles naturally end up in the liver, says Siegwart. So, a few years ago ...

IMT treatment significantly reduced hepatosteatosis in HFD-fed mice, accompanied by decreased liver lipid content and weight. A reversal of diglyceride and triglyceride accumulation was observed ...

Immunotherapy reduces lung and liver fibrosis in mice The researchers then used these two surface structures as a vaccine in mice in order to trigger an immune response via cytotoxic T-cells.